| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) | 
|---|
| 06/11/2014 | CN103857668A Ethynyl derivatives as mglur5 allosteric modulators | 
| 06/11/2014 | CN103857661A 1,2,4-triazolyl-substituted keto-enols | 
| 06/11/2014 | CN103857659A Fused benzoxazepinones as ion channel modulators | 
| 06/11/2014 | CN103848829A Heteroaryl alkyne compounds and application thereof | 
| 06/11/2014 | CN103848822A 1,8-carbazole derivative, preparation method and application thereof in luminescent device | 
| 06/11/2014 | CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition | 
| 06/11/2014 | CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs | 
| 06/11/2014 | CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs | 
| 06/11/2014 | CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs | 
| 06/11/2014 | CN103848817A Iodination preparation method for dipeptidyl peptidase inhibitor, chlorination and iodination intermediates of dipeptidyl peptidase inhibitor and preparation methods for intermediates | 
| 06/11/2014 | CN103848816A Reductive amination preparation method for dipeptidyl peptidase inhibitor, and intermediate and preparation method thereof | 
| 06/11/2014 | CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor | 
| 06/11/2014 | CN103848810A Bruton's tyrosine kinases inhibitor | 
| 06/11/2014 | CN102947289B Arylethynyl derivatives | 
| 06/11/2014 | CN102596936B Antiviral compounds | 
| 06/11/2014 | CN102256963B Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd | 
| 06/10/2014 | US8748603 Crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]THIO]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide | 
| 06/10/2014 | US8748597 2,4-pyrimidinediamine compounds and their uses | 
| 06/10/2014 | US8748442 sGC stimulators | 
| 06/10/2014 | US8748433 β3 adrenergic receptor agonists | 
| 06/10/2014 | US8748432 Microbiocidal pyrazole derivatives | 
| 06/10/2014 | US8748426 Inhibitors of diacylglycerol acyl transferase | 
| 06/10/2014 | CA2541509C Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | 
| 06/05/2014 | WO2014085528A1 Azaquinazoline carboxamide derivatives | 
| 06/05/2014 | WO2014085490A1 Cxcr7 antagonists | 
| 06/05/2014 | WO2014084778A1 Pyrimidine-2,4-diamine derivatives for treatment of cancer | 
| 06/05/2014 | WO2014084612A1 Novel compound and organic electronic element using same | 
| 06/05/2014 | WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx | 
| 06/05/2014 | WO2014082598A1 Inhibitors of bruton's tyrosine kinase | 
| 06/05/2014 | WO2014082578A1 Heteroaryl alkyne compound and application thereof | 
| 06/05/2014 | WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof | 
| 06/05/2014 | WO2014082380A1 Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof | 
| 06/05/2014 | WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention | 
| 06/05/2014 | WO2013106689A8 Hcv ns3 protease inhibitors | 
| 06/05/2014 | US20140155625 Modified Naturally-Derived Colorants For Phase Change Ink Applications | 
| 06/05/2014 | US20140155602 Arlethynyl Derivatives | 
| 06/05/2014 | US20140155447 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | 
| 06/05/2014 | US20140155421 Substituted pyrimidinyl-pyrroles active as kinase inhibitors | 
| 06/05/2014 | US20140155418 Receptor-Type Kinase Modulators and Methods of Use | 
| 06/05/2014 | US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | 
| 06/05/2014 | US20140155407 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases | 
| 06/05/2014 | US20140155402 Bi-heteroaryl compounds as vps34 inhibitors | 
| 06/05/2014 | US20140155386 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors | 
| 06/05/2014 | US20140155382 Anti-viral compounds | 
| 06/05/2014 | US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors | 
| 06/05/2014 | US20140155370 Nuclear transport modulators and uses thereof | 
| 06/05/2014 | US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta | 
| 06/04/2014 | EP2738165A1 Method by means of phase transfer catalysis | 
| 06/04/2014 | EP2736902A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors | 
| 06/04/2014 | EP2736901A1 Heterocyclyl pyrimidine analogues as jak inhibitors | 
| 06/04/2014 | EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators | 
| 06/04/2014 | EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors | 
| 06/04/2014 | EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof | 
| 06/04/2014 | EP2736883A1 Nuclear transport modulators and uses thereof | 
| 06/04/2014 | EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors | 
| 06/04/2014 | CN103842340A Nuclear transport modulators and uses thereof | 
| 06/04/2014 | CN103833997A New compound with tozasertib structure as well as preparation method and application thereof | 
| 06/04/2014 | CN103833736A Method for preparing avanafil | 
| 06/04/2014 | CN103833735A Compound for preventing and treating grape downy mildew and composition employing same | 
| 06/04/2014 | CN103833734A Synthesis method of N-aminoethyl terpinene maleimido imidazole derivative | 
| 06/04/2014 | CN103833733A New crystal form of tini-type medicines | 
| 06/04/2014 | CN103833658A Benzotriazole-based piperazine compound as well as preparation method and pharmaceutical composition thereof | 
| 06/04/2014 | CN103833643A Benzimidazolyl-piperazine compound and preparation method and pharmaceutical composition thereof | 
| 06/04/2014 | CN103833642A Application of benzo five-membered nitrogen-containing heterocycle-based piperazine derivative | 
| 06/04/2014 | CN103833544A 11-beta-hydroxysteroid dehydrogenase type i inhibitors | 
| 06/04/2014 | CN102712624B Indole compound and pharmaceutical use thereof | 
| 06/04/2014 | CN102696622B Pesticide composition capable of preventing and controlling plant disease | 
| 06/04/2014 | CN102659685B Process for preparing N-substituted azole derivatives under the catalytic action of metallic iron salt | 
| 06/04/2014 | CN102369187B N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators | 
| 06/04/2014 | CN101861313B Phenyl amino pyrimidine compounds and uses thereof | 
| 06/04/2014 | CN101379058B Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases | 
| 06/03/2014 | US8742331 Imidazolium-based liquid salts and methods of use thereof | 
| 06/03/2014 | US8742135 Compound amycolamicin, method for producing the same, and use of the same | 
| 06/03/2014 | US8742133 Triazole compounds that modulate HSP90 activity | 
| 06/03/2014 | US8742100 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity | 
| 06/03/2014 | US8742097 Triazole compounds I | 
| 06/03/2014 | US8741944 Anti-infective agents against intracellular pathogens | 
| 06/03/2014 | US8741943 Bicyclic compound, production and use thereof | 
| 06/03/2014 | US8741942 Inhibitors of cellular necrosis | 
| 06/03/2014 | US8741914 Antiviral compounds and uses thereof | 
| 06/03/2014 | US8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors | 
| 06/03/2014 | US8741450 Material for organic electroluminescence devices and organic electroluminescence device using the material | 
| 06/03/2014 | CA2590110C Kinase modulators and method of use | 
| 06/03/2014 | CA2563063C Purification of progesterone receptor modulators | 
| 05/30/2014 | WO2014081697A2 Anthelmintic compounds and compositions and method of using thereof | 
| 05/30/2014 | WO2014081689A1 Compounds useful as inhibitors of indoleamine 2,3-dioxygenase | 
| 05/30/2014 | WO2014081388A1 Dopants for solid-state dye-sensitive solar cells | 
| 05/30/2014 | WO2014081206A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same | 
| 05/30/2014 | WO2014081134A1 Novel compound and organic electroluminescent element comprising same | 
| 05/30/2014 | WO2014079806A1 Pyrimidine compounds for treating hairloss | 
| 05/30/2014 | WO2014079803A1 Bicyclosubstituted pyrazole compounds for treating hairloss | 
| 05/30/2014 | WO2014079155A1 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives | 
| 05/30/2014 | WO2014079154A1 Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof | 
| 05/30/2014 | WO2014055972A3 A new chemical entity useful for treating various diseases | 
| 05/30/2014 | WO2014043252A3 Hydroxypyridinone-,hydroxypyrimidinone-and hydroxypyridazinone drivatives and their therapeutic application | 
| 05/29/2014 | US20140148463 Pyridazinone derivatives | 
| 05/29/2014 | US20140148462 Indanyloxydihydrobenzofuranylacetic acids | 
| 05/29/2014 | US20140148459 Matrix metalloproteinase inhibitors | 
| 05/29/2014 | US20140148448 Inhibitors of c-fms kinase | 
| 05/29/2014 | US20140148443 Novel Imidazolines as dual inhibitors of MDM2 and MDMX |